MannKind to Present at Investor Conferences in September 2025

Friday, Aug 29, 2025 12:38 pm ET1min read

MannKind Corporation (MNKD) to participate in four investor conferences in September 2025. CEO Michael Castagna and CFO Chris Prentiss will present and provide updates at each event. Live webcasts will be accessible on MannKind's website, with recordings available for 90 days post-event. MannKind is dedicated to innovation, focusing on the development and commercialization of novel inhalation therapies for endocrine and orphan lung diseases.

MannKind to Present at Investor Conferences in September 2025

Comments



Add a public comment...
No comments

No comments yet